Clinical TrialsSearch results
Number of results: 858
Other
- A Phase III Randomized, Multicenter Study Comparing Irinotevan and Cisplatin (IP) with Amrubicin and Cisplatin (AP) for the Treatment of Extensive-Stage Small-Cell Lung Cancer: (JCOG0509)
- extensive-disease small cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2007-05-22
Other
- A Phase III Study Comparing Etoposide and Cisplatin (EP) with Irinotecan and Cisplatin (IP) following EP plus Concurrent Accelerated Hyperfractionated Thoracic Irradiation (EP/TRT) for the Treatment of Limited-Stage Small-Cell Lung Cancer (EP/TRT-IPIII): JCOG0202-MF
- Limited-Stage Small-Cell Lung Cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-08-30
Other
- A Phase III Study Comparing Irinotecan, Cisplatin and Etoposide (PEI) with Nogitecan for the Treatment of Relapsed Small-Cell Lung Cancer (JCOG0605)
- Sensitive relpased small-cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2007-09-20
Other
- A phase III study of covered versus bare metallic stents for the treatment of malignant bile duct obstruction (JIVROSG-0207)
- Malignant common bile duct obstruction
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-06
Other
- A Phase III Study of Docetaxel and S-1 versus S-1 in the Treatment of Advanced Gastric Cancer
- Gastric Cancer
- Japan Clinical Cancer Research Organization
- 2005-11-01
Recruiting
- A Phase III Study of FYU-981 in Hyperuricemic Pediatric Patients with or without Gout (Extension Study)
- Hyperuricemic pediatric patients with or without gout
- Fushimi Masahiko
- 2022-08-31
Other
- A Phase III Study of Intra-Arterial Hepatic Chemotherapy with 5-FU (WHF) in Patients with Liver Metastases from Colorectal Carcinoma
- Liver excision;liver metastasis cancer of colorectal cancer origin
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2005-08-25
Other
- A phase III trial comparing preoperative chemotherapy to chemoradiotherapy before surgery in patients with pathologically-confirmed stage IIIA-N2 non-small cell lung cancer.
- Pathologically confirmed stage IIIA-N2 non-small cell lung cancer
- West Japan Oncology Group
- 2005-09-14
Other
- A Phase III, Multicentre, International Study With a Parallel, Randomised, Double-blind, Placebo-controlled, 2 Arm Design to Assess the Efficacy and Safety of Selumetinib in Adult Participants With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas
- Neurofibromatosis 1, Plexiform Neurofibroma (PN)
- Kobayashi Hiroshi
- 2021-06-24
Recruiting
- A Phase III, Randomized, Open-Label, Multi-Center, Global Study of Volrustomig (MEDI5752) as Sequential Therapy Versus Observation in Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma, Who Have Not Progressed Following Definitive Concurrent Chemoradiotherapy (eVOLVE-HNSCC)
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- Hibi Kazushige
- 2024-01-11